Author: Lin Fu; Jun Fei; Shen Xu; Hui-Xian Xiang; Ying Xiang; Zhu-Xia Tan; Meng-Die Li; Fang-Fang Liu; Ying Li; Ming-Feng Han; Xiu-Yong Li; Hui Zhao; De-Xiang Xu
Title: Acute liver injury and its association with death risk of patients with COVID-19: a hospital-based prospective case-cohort study Document date: 2020_4_6
ID: 5gbjdr0u_20
Snippet: The effects of ALI at the early stage on death risk are presented in Table 3 . Among 151 COVID-19 patients with cholestasis, 13.9% were died. The fatality rate was higher among COVID-19 patients with cholestasis than those without cholestasis (13.9 % vs 6.4%; RR=2.182, 95% Cl: 1.129, 4.218; P<0.05). As shown in Table 3 , there was no significant association between hepatocellular injury and death risk among COVID-19 patients......
Document: The effects of ALI at the early stage on death risk are presented in Table 3 . Among 151 COVID-19 patients with cholestasis, 13.9% were died. The fatality rate was higher among COVID-19 patients with cholestasis than those without cholestasis (13.9 % vs 6.4%; RR=2.182, 95% Cl: 1.129, 4.218; P<0.05). As shown in Table 3 , there was no significant association between hepatocellular injury and death risk among COVID-19 patients.
Search related documents:
Co phrase search for related documents- death injury and early stage: 1, 2, 3, 4, 5, 6, 7
- death injury and fatality rate: 1, 2
- death injury and patient death injury risk: 1, 2
- death injury and significant association: 1, 2, 3, 4, 5
- death injury risk and early stage: 1, 2, 3
- death injury risk and fatality rate: 1
- death injury risk and patient death injury risk: 1, 2
- death risk and early stage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61
- death risk and fatality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- death risk and patient death injury risk: 1, 2
- death risk and significant association: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60
- death risk early stage and early stage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- death risk early stage and fatality rate: 1, 2, 3, 4, 5, 6
- early stage and fatality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- early stage and significant association: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- fatality rate and significant association: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
Co phrase search for related documents, hyperlinks ordered by date